Chengqin Wang
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
TRAIP promotes the development of papillary thyroid cancer by inhibiting TRAF2-mediated BRAF ubiquitination.
Journal: The Journal of biological chemistry
Published: March 17, 2026
Chemerin Promotes Oral Squamous Cell Carcinoma Progression via NLRP3-Mediated Pyroptosis and the GSDMD-N Pathway.
Journal: International dental journal
Published: October 08, 2025
Mutational analysis and protein expression of PI3K/AKT pathway in four mucinous cystadenocarcinoma of the breast.
Journal: Diagnostic pathology
Published: February 06, 2025
TRAIP enhances progression of tongue squamous cell carcinoma through EMT and Wnt/β-catenin signaling by interacting with DDX39A.
Journal: BMC cancer
Published: April 15, 2024
Research status and controversy on non-small cell lung cancer stem cells.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: December 09, 2023
Screening for metastasis-related genes in mouse melanoma cells through sequential tail vein injection.
Journal: Biophysics reports
Published: December 05, 2023
Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients.
Journal: Breast cancer research and treatment
Published: July 11, 2023
Neutrophils regulate tumor angiogenesis in oral squamous cell carcinoma and the role of Chemerin.
Journal: International immunopharmacology
Published: April 16, 2023
Spatial immunophenotypes orchestrate prognosis in triple-negative breast cancer with Miller-Payne grade 4 following neoadjuvant chemotherapy.
Journal: NPJ breast cancer
Published: January 23, 2023
A single administration of FGF2 after renal ischemia-reperfusion injury alleviates post-injury interstitial fibrosis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 04, 2022
Silencing TRAIP suppresses cell proliferation and migration/invasion of triple negative breast cancer via RB-E2F signaling and EMT.
Journal: Cancer gene therapy
Published: February 11, 2022
Last Updated: 09/26/2026